Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Veszprem – page 3

259 clinical trials in Veszprem, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Veszprem at a glance
259
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

259 trials in Veszprem

Open in trial search

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Crohn's disease

Recruiting

Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:MORF-057
  • Sponsor:Morphic Therapeutic Inc.

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Cardiac failure

Recruiting

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Zenagamtide versus semaglutide: a study of blood sugar and weight reduction in adults with type 2 diabetes inadequately controlled on metformin and/or SGLT2 inhibitor

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

A Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Eli Lilly & Co.

Obesity

Recruiting

Long‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Drocamorelin
  • Sponsor:AnaCardio AB

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Veszprem

What the registry says about research in the country

01 Psoriasis Research

Comprehensive studies evaluating novel treatments for moderate to severe plaque psoriasis, including investigations of innovative therapies like JNJ-77242113 and ESK-001.

  • Plaque Psoriasis Treatment Trials
  • Long-term Safety Studies
  • Special Areas Treatment Research

Multiple trials focusing on efficacy assessment and treatment response durability.

02 Psoriatic Arthritis Studies

Extensive research into psoriatic arthritis treatments, including trials with zasocitinib, sonelokimab, and deucravacitinib for both biologic-naïve and experienced patients.

  • Biologic DMARD Studies
  • Novel Treatment Approaches
  • Axial Disease Research

Focus on reducing symptoms and improving quality of life for patients.

03 Autoimmune Conditions

Innovative research targeting systemic lupus erythematosus and other inflammatory conditions, with studies on medications like GLPG3667 and upadacitinib.

  • Lupus Treatment Trials
  • Rheumatoid Arthritis Studies
  • Long-term Safety Evaluations

Comprehensive evaluation of disease activity and treatment responses.

04 Osteoarthritis Research

Studies examining treatments for knee osteoarthritis, including comparative analysis of different chondroitin sulfate formulations and novel compounds.

  • Pain Management Studies
  • Therapeutic Comparisons
  • Functional Improvement Assessment

Focus on both symptom management and functional outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.